[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 18.206.16.123. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 373
Citations 0
Comment & Response
August 20, 2019

Monitoring Adherence to Inhaled Medications—Reply

Author Affiliations
  • 1Allergy, Asthma, and Clinical Immunology Service, The Alfred Hospital, Melbourne, Victoria, Australia
  • 2Woolcock Institute of Medical Research, University of Sydney, Sydney, New South Wales, Australia
JAMA. 2019;322(7):693-694. doi:10.1001/jama.2019.8654

In Reply While we agree with the important points that Dr Bryant and colleagues have made about the role of multidisciplinary teams in improving adherence,1-4 we believe they may have misinterpreted our main thesis5 by inadvertently conflating adherence monitoring with adherence management. We have argued that input from pharmaceutical companies is essential to rectify the current lack of adherence monitoring. We do not, however, equate this with delivering overall adherence management, which is a far broader endeavor, needing to take into account multiple contributory factors and requiring an adequately resourced multidisciplinary approach, beyond the remit of any pharmaceutical company.

×